American Journal of Cardiology
Volume 105, Issue 8 , Pages 1122-1129 , 15 April 2010

Practice Patterns Among United States Cardiologists for Managing Adults With Atrial Fibrillation (from the AFFECTS Registry)

  • James A. Reiffel, MD

      Affiliations

    • Columbia University, New York, New York
    • Corresponding Author InformationCorresponding author: Tel: 212-305-5206; fax: 212-305-5155
    • ,
  • Peter R. Kowey, MD

      Affiliations

    • Jefferson Medical College, Philadelphia, Pennsylvania
    • ,
  • Robert Myerburg, MD

      Affiliations

    • University of Miami, Miami, Florida
    • ,
  • Gerald V. Naccarelli, MD

      Affiliations

    • Penn State College of Medicine, Hershey, Pennsylvania
    • ,
  • Douglas L. Packer, MD

      Affiliations

    • Mayo Clinic, Rochester, Minnesota
    • ,
  • Craig M. Pratt, MD

      Affiliations

    • Baylor College of Medicine, Houston, Texas
    • ,
  • Michael J. Reiter, MD, PhD

      Affiliations

    • University of Colorado, Denver, Colorado
    • ,
  • Albert L. Waldo, MD

      Affiliations

    • University Hospitals Case Medical Center, Cleveland, Ohio
    • ,
  • AFFECTS Scientific Advisory Committee and Investigators

Received 18 August 2009 ,Revised 19 November 2009 ,Accepted 19 November 2009.

References 

  1. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary (A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology). J Am Coll Cardiol. 2001;38:1231–1266
  2. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e257–e354
  3. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000;356:1789–1794
  4. Opolski G, Torbicki A, Kosior DA, Szulc M, Wozakowska-Kaplon B, Kolodziej P, et al. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) study. Chest. 2004;126:476–486
  5. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834–1840
  6. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833
  7. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation. 2004;109:1509–1513
  8. Patton K, Page R. Pharmacological therapy of atrial fibrillation. Expert Opin Invest Drugs. 2007;16:169–179
  9. Kowey PR, Reiffel JA, Myerburg R, Naccarelli GV, Packer DL, Pratt CM, et al. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS registry). Am J Cardiol. 2010;105:1130–1134
  10. Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation. Circ J. 2009;73:242–248
  11. Curtis AB, Seals AA, Safford RE, Slater W, Tullo NG, Vidaillet H, et al. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study. Am Heart J. 2005;149:304–308
  12. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA. 2001;285:2370–2375

 This study was sponsored by Reliant Pharmaceuticals, Liberty Corner, New Jersey (acquired by GlaxoSmithKline, London, United Kingdom), and by Columbia University, New York, New York.

 The full list of investigators appears in the Appendix to the online version of this report.

PII: S0002-9149(09)02842-2

doi: 10.1016/j.amjcard.2009.11.046

American Journal of Cardiology
Volume 105, Issue 8 , Pages 1122-1129 , 15 April 2010

Article Tools

* Image Usage & Resolution